Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Arch Therapeutics Inc (ARTH)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.2100 +0.0300    +2.54%
12:30:00 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 7,396
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 1.1950 - 1.2150
Arch Therapeutics 1.2100 +0.0300 +2.54%

ARTH Recent Sentiments

 
This page contains information on users’ sentiments for the Arch Therapeutics Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Jan 08, 2024 Al Blanch   6.2500 Feb 02, 2024 @ 3.1500 -49.60%
Dec 15, 2023 Kian Palmer   4.4500 Jan 05, 2024 @ 5.1900 +16.63%
Jun 11, 2021 Alfred Lorenzini   0.1031 Jul 02, 2021 @ 0.0952 -7.66%
Apr 22, 2021 Attila Toth   0.1400 Apr 26, 2021 @ 0.1250 -10.71%
Dec 31, 2020 neil mortimer   0.1520 Jan 22, 2021 @ 0.1900 +25.00%
Jul 01, 2020 Kun Qian   0.1545 Jul 24, 2020 @ 0.1740 +12.62%
May 26, 2020 Kun Qian   0.1875 Jun 19, 2020 @ 0.1780 +5.07%
Apr 13, 2020 Timo Ojala   0.2199 May 08, 2020 @ 0.1900 -13.60%
Jan 02, 2020 Mihaescu Marius   0.2348 Jan 24, 2020 @ 0.2320 -1.19%
Dec 12, 2019 Marius Mihaescu   0.2400 Jan 03, 2020 @ 0.2347 +2.21%
Nov 25, 2019 Brian C   0.1900 Dec 20, 2019 @ 0.2293 +20.68%
Jul 18, 2019 neil mortimer   0.3250 Aug 09, 2019 @ 0.2810 -13.54%
Apr 12, 2019 Timo Ojala   0.3600 May 03, 2019 @ 0.3450 -4.17%
Jan 24, 2019 Brian C   0.3925 Feb 24, 2019 @ 0.3900 -0.64%
Dec 17, 2018 Neil Mortimer   0.5850 Jan 16, 2019 @ 0.4810 -17.78%
Sep 20, 2018 Brian C   0.3950 Oct 20, 2018 @ 0.4810 +21.77%
Sep 13, 2018 Neil Mortimer   0.4400 Oct 13, 2018 @ 0.4810 +9.32%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ARTH Comments

Write your thoughts about Arch Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
neil mortimer
neil mortimer Feb 25, 2021 1:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy,buy,buy
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email